Revolutionizing Atopic Dermatitis

Bunick provides an overview of the most important highlights from his late-breaking session at RAD 2023.

Andrew Blauvelt, MD, MBA, discusses his RAD 2023 session, "Biologics for atopic dermatitis."

Andrew Blauvelt, MD, MBA, shares highlights from his RAD session, "Battle of the Titans 2: Challenging Patient Cases: Who is Eligible for Systemic Treatment in Atopic Dermatitis?"

A recently presented poster session from RAD 2023 evaluated a gene expression based molecular test’s differential diagnosis of psoriasis and eczema.

Among numerous sessions to be held this weekend at the Revolutionizing Atopic Dermatitis Conference in Washington, DC, several Dermatology Times® Editorial Advisory Board members are preparing to share their knowledge and insights.

Catch up on coverage from the first day of Revolutionizing Atopic Dermatitis.

Revolutionizing Atopic Dermatitis Conference Chair Jonathan Silverberg, MD, PhD, MPH, previews this weekend's conference in Washington, DC.

The RAD conference provides the chance to take a deep dive into one specific disease state in a focused setting.

When sessions, late-breaking research, and more concludes, there is no shortage of things to do in the nation’s capital.

The 5th annual RAD conference kicks off April 29, 2023, in Washington, DC.

Let us know what content you want to see from RAD.

Click here to answer this week's poll.

Catch up on coverage from the 2022 Revolutionizing Atopic Dermatitis Conference.

At the RAD 2022 Conference, Keri Kelley, Senior Outreach and Community Manager at Global Parents for Eczema Research discussed a program aimed at providing support for eczema caregivers.

At the RAD 2022 Conference, Steve Xu, MD, MSc, explains how a wearable sensor can better track the progression of atopic dermatitis while a patient is sleeping.

Jonathan Silverberg, MD, PhD, MPHS, gives an overview of topical therapies for atopic dermatitis at the 2022 virtual RAD conference.

At the 2022 RAD virtual conference, a dermatologist examines treatment options for AD in various racial and ethnic groups.

A 2022 RAD Conference abstract presentation showed the epidemiology of type 2 associated conditions included in patients with AD.

At the 2022 RAD Conference, a Harvard University psychologist discusses ways that practitioners can help identify and treat children with adverse mental health outcomes as a result of atopic dermatitis.

A 2022 RAD Conference poster presentation explores the efficacy of the therapy for the treatment or prevention of AD.

A 2022 RAD Conference poster presentation explored how to better support caregivers of children with atopic dermatitis.

A poster presentation from the 2022 RAD Conference analyzed manifestations of atopic dermatitis across racial groups.

Raj Chovatiya, MD, PhD, gives a preview of his discussions on topical formulations of atopic dermatitis and advancing therapeutic expectations at this weekend’s RAD conference.

The Revolutionizing Atopic Dermatitis Conference takes place on December 11th, 2022.

Mona Shahriari, MD, Assistant Clinical Professor of Dermatology at Yale University School of Medicine, shares what she is looking forward to at the Revolutionizing Atopic Dermatitis virtual conference.

Korey Capozza, MPH, Executive Director of Global Parents for Eczema Research, shares what she is looking forward to at the Revolutionizing Atopic Dermatitis virtual conference.

Jonathan Silverberg, MD, PHD, MPHS, talks about the exciting highlights of the Revolutionizing Atopic Dermatitis virtual conference on December 11.

Robert Sidbury, MD, MPH, the division chief of dermatology at Seattle Childrens, talks about how education of patients is so important, the upcoming parts of the AAD guidelines to look forward to, and more.

Korey Capozza, MPH, the founder and executive director of Global Parents for Eczema Research expands on her talk from the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference is held from April 9 to 11 in Baltimore, Maryland.

Lawrence Eichenfield, MD, of Rady Children's Hospital-San Diego, discusses the American Academy of Dermatology's approach to atopic dermatitis management.